Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study

Clicks: 427
ID: 269932
2009
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #27 of 161 articles by views in Lancet (London, England)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 161 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Wellcome Trust, UK.
Reference Key
tn2009lancetbacteraemia Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Williams TN;Uyoga S;Macharia A;Ndila C;McAuley CF;Opi DH;Mwarumba S;Makani J;Komba A;Ndiritu MN;Sharif SK;Marsh K;Berkley JA;Scott JA;;
Journal Lancet (London, England)
Year 2009
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/19747721
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adolescent Child Infant newborn preschool Retrospective Studies Rural Population anti-bacterial agents / therapeutic use case-control studies Cohort Studies odds ratio j anthony g scott kenya anemia bacteremia / drug therapy bacteremia / microbiology* bacteremia / diagnosis thomas n williams pmid:19747721 pmc2768782 doi:10.1016/s0140-6736(09)61374-x sophie uyoga sickle cell / complications* sickle cell / mortality

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.